Mimedx (MDXG) Revenue (2011 - 2026)

Mimedx has disclosed Revenue across 16 years of filings, most recently posting $64.4 million for Q2 2026.

• In Q2 2026, Revenue fell 34.73% year-over-year to $64.4 million; the TTM figure through Jun 2026 stood at $355.2 million (down 2.36% YoY), while the FY2025 annual figure was $418.6 million, up 19.99% from the prior year.
• Revenue came in at $64.4 million for Q2 2026 at Mimedx, up from $59.0 million in the prior quarter.
• In the past five years, Revenue ranged from a high of $118.1 million in Q4 2025 to a low of $58.9 million in Q1 2022.
• Average Revenue over 5 years is $82.2 million, with a median of $82.9 million recorded in 2023.
• Year-over-year, Revenue jumped 46.37% in 2022 and slumped 34.73% in 2026.
• Over 5 years, Revenue stood at $74.4 million in 2022, then rose by 16.75% to $86.8 million in 2023, then gained by 7.0% to $92.9 million in 2024, then advanced by 27.11% to $118.1 million in 2025, then tumbled by 45.5% to $64.4 million in 2026.
• Per Business Quant data, the three most recent Revenue figures were $64.4 million in Q2 2026, $59.0 million in Q1 2026, and $118.1 million in Q4 2025.